The success of clinical immunosuppressive trials in heart transplantation: the early detection of acute rejection

1999 ◽  
pp. 57-59
Author(s):  
M. Antoine
2015 ◽  
Vol 34 (4) ◽  
pp. S296
Author(s):  
S. Wallner ◽  
J. Gökler ◽  
U. Just ◽  
R. Knobler ◽  
T. Horner-Golden ◽  
...  

Author(s):  
Y. S. Boriskin ◽  
J. C. Booth ◽  
C. M. Corbishley ◽  
B. P. Madden ◽  
W. J. McKenna ◽  
...  

Author(s):  
A. О. Shevchenko

Statins should be used as a part of standard therapy in patients after heart transplantation. The effectiveness of statins is associated not only with their hypolipidemic action, but also with their immunomodulatory and antineoplastic properties. Statin therapy initiated early after heart transplantation improves the shortand long-term prognosis and outcomes, leading to a reduction in the incidence of cardiac allograft vasculopathy, acute rejection, and cancer. 


1989 ◽  
Vol 2 (1) ◽  
pp. 143-146 ◽  
Author(s):  
T. J. Locke ◽  
R. Karnik ◽  
C. G. A. McGregor ◽  
R. S. Bexton

2018 ◽  
Vol 32 (10) ◽  
pp. e13373
Author(s):  
Hui Tzu Lin-Wang ◽  
Reginaldo Cipullo ◽  
João Italo Dias França ◽  
Marco Aurelio Finger ◽  
Joao Manoel Rossi Neto ◽  
...  

2020 ◽  
Vol 5 (3) ◽  
pp. 100055
Author(s):  
Tomasz Urbanowicz ◽  
Dominika Konecka-Mrówka ◽  
Jerzy Nożyński ◽  
Marek Jemielity

Sign in / Sign up

Export Citation Format

Share Document